Ewing Sarcoma

- References

1) Gomez-Brouchet, A., Mascard, E., Siegfried, A., de Pinieux, G., Gaspar, N., Bouvier, C., Aubert, S., Marec-Bérard, P., Piperno-Neumann, S., Marie, B., Larousserie, F., Galant, C., Fiorenza, F., Anract, P., Sales de Gauzy, J., & Gouin, F. (2019). Assessment of resection margins in bone sarcoma treated by Neoadjuvant Chemotherapy: Literature review and guidelines of the Bone Group (GROUPOS) of the French sarcoma group and Bone Tumor Study Group (GSF-geto/RESOS). Orthopaedics & Traumatology: Surgery & Research, 105(4), 773–780.

2) Kissane JM, Askin FB, Foulkes M, et al. Ewing's sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing's Sarcoma Study. Hum Pathol 1983; 14:773-779.

3) Spector, L. G., Hubbard, A. K., Diessner, B. J., Machiela, M. J., Webber, B. R., & Schiffman, J. D. (2021). Comparative international incidence of Ewing Sarcoma 1988 to 2012. International Journal of Cancer, 149(5), 1054–1066.

4) Treglia G, Salsano M, Stefanelli A, et al. Diagnostic accuracy of (1)(8)F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. Skeletal Radiol 2012; 41:249-256.

5) Siegel MJ, Acharyya S, Hoffer FA, et al. Whole-body MR imaging for staging of malignant tumors in pediatric patients: results of the American College of Radiology Imaging Network 6660 Trial. Radiology 2013; 266:599-609.

6) Boddu S, Walko CM, Bienasz S, et al. Clinical Utility of Genomic Profiling in the Treatment of Advanced Sarcomas: A Single-Center Experience. JCO Precision Oncology 2018:1-8.

7) Campbell KM, Shulman DS, Grier HE, DuBois SG. Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review. Pediatr Blood Cancer 2021;68: e28807.

8) Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long- term follow-up of the First Intergroup study. J Clin Oncol 1990; 8:1664- 1674.

9) Burgert EO, Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II. J Clin Oncol 1990; 8:1514-1524.

10) Kolb EA, Kushner BH, Gorlick R, et al. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 2003; 21:3423-3430.

11) Shamberger RC, LaQuaglia MP, Gebhardt MC, et al. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 2003; 238:563-567; discussion 567-568.

12) Brennan B, Kirton L, Marec-Berard P, et al. Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012). Journal of Clinical Oncology 2020; 38:11500-11500.

13) Womer RB, West DC, Krailo MD, et al. Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report from the Children's Oncology Group. Journal of Clinical Oncology 2012; 30:4148-4154.

14) Yock TI, Krailo M, Fryer CJ, et al. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. J Clin Oncol 2006; 24:3838-3843.

15) Dunst J, Jurgens H, Sauer R, et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys 1995; 32:919-930.

16) Schuck A, Ahrens S, von Schorlemer I, et al. Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2005; 63:1562-1567.

17) DuBois SG, Krailo MD, Gebhardt MC, et al. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer 2015; 121:467-475.

18) Indelicato DJ, Keole SR, Shahlaee AH, et al. Definitive radiotherapy for ewing tumors of extremities and pelvis: long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys 2008; 72:871-877.

19) Haeusler J, Ranft A, Boelling T, et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer 2010; 116:443-450.

20) Paulino AC, Mai WY, Teh BS. Radiotherapy in metastatic Ewing sarcoma. Am J Clin Oncol 2013; 36:283-286.

21) Baumann BC, Nagda SN, Kolker JD, et al. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection. J Surg Oncol 2016; 114:65-69.

22) Bolling T, Schuck A, Paulussen M, et al. Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial. Strahlenther Onkol 2008; 184:193-197.

23) Casey DL, Wexler LH, Meyers PA, et al. Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer 2015; 62:445-449.

24) Mirzaei, L., Kaal, S. E. J., Schreuder, H. W. B., & Bartels, R. H. M. A. (2015). The neurological compromised spine due to Ewing sarcoma. what first. Neurosurgery, 77(5), 718–725.

25) Boussios, S., Hayward, C., Cooke, D., Zakynthnakis-Kyriakou, N., Tsiouris, A. K., Chatziantoniou, A. A., Kanellos, F. S., & Karathanasi, A. (2018). Spinal Ewing sarcoma debuting with cord compression: Have we discovered the thread of Ariadne? Anticancer Research, 38(10), 5589–5597.

26) Dunst J, Schuck A. Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer 2004; 42:465-470.

27) Raciborska A, Bilska K, Drabko K, et al. Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma. Pediatr Blood Cancer 2013; 60:1621-1625.

28) Van Winkle P, Angiolillo A, Krailo M, Cheung YK, Anderson B, Davenport V, Reaman G, Cairo MS. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience. Pediatr Blood Cancer. 2005 Apr;44(4):338-47.

29) Xue R, Lewis VO, Moon BS, Lin PP. Local recurrence of Ewing sarcoma: Is wide excision an acceptable treatment? J Surg Oncol 2019; 120:746-752.

30) Robinson SI, Ahmed SK, Okuno SH, et al. Clinical outcomes of adult patients with relapsed Ewing sarcoma: a 30-year single-institution experience. Am J Clin Oncol 2014; 37:585-591.

31) Bacci G, Forni C, Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004; 40:73-83.